PCI Biotech: Mandatory notification regarding trade of shares
Borkenholm AS has on 29 August 2019 bought 4,000 shares in PCI Biotech Holding ASA ("PCI Biotech") at an average price of NOK 26.90 per share. Borkenholm AS is a related party to board member Hilde Furberg.
After the transaction, Hilde Furberg and her related parties holds 4,000 shares in PCI Biotech.
This information is subject to the disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act.
Upcoming Life Sciences Events
- April 2024
- Basel: Swiss Biotech Day 2024
- London: BioTrinity 2024
- Singapore: Asia Bio Partnering Forum
Latest company news
There are currently no news available for this portal